Literature DB >> 7107172

Vasodilator therapy of pulmonary hypertension in the CRST syndrome.

J McWeeney, P Finnegan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107172     DOI: 10.1007/BF02940166

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  12 in total

1.  THE PATHOPHYSIOLOGY OF SCLERODERMA INVOLVING THE HEART AND RESPIRATORY SYSTEM.

Authors:  M A SACKNER; N AKGUN; P KIMBEL; D H LEWIS
Journal:  Ann Intern Med       Date:  1964-04       Impact factor: 25.391

2.  Primary pulmonary hypertension favorable effect of isoproterenol.

Authors:  U R Shettigar; H N Hultgren; M Specter; R Martin; D H Davies
Journal:  N Engl J Med       Date:  1976-12-16       Impact factor: 91.245

3.  Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.

Authors:  F S Daoud; J T Reeves; D B Kelly
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

4.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05

5.  Oral hydralazine therapy for primary pulmonary hypertension.

Authors:  L J Rubin; R H Peter
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

6.  Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.

Authors:  M Honey; L Cotter; N Davies; D Denison
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

7.  Pulmonary vascular changes in scleroderma.

Authors:  R H Young; G J Mark
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

8.  Primary pulmonary hypertension: effects of nifedipine.

Authors:  F Camerini; E Alberti; S Klugmann; A Salvi
Journal:  Br Heart J       Date:  1980-09

9.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

Authors:  R Salerni; G P Rodnan; D F Leon; J A Shaver
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).

Authors:  E E Velayos; A T Masi; M B Stevens; L E Shulman
Journal:  Arch Intern Med       Date:  1979-11
View more
  1 in total

1.  Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.

Authors:  I J Russell; R A Walsh
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.